Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.18B 580M 515M 482M 439M 826M 55.83B 838M 5.83B 2.26B 28.43B 2.13B 91.32B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.21B 588M 522M 488M 445M 837M 56.58B 849M 5.91B 2.29B 28.82B 2.16B 92.56B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day-1.50%
1 week-3.12%
Current month-1.50%
1 month-8.26%
3 months+1.97%
6 months+12.27%
Current year-2.11%
1 week 61.9
Extreme 61.9
64.55
1 month 61.9
Extreme 61.9
67.8
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 2018-09-04
Director of Finance/CFO - 2024-03-10
Chief Tech/Sci/R&D Officer 51 2022-12-31
Director TitleAgeSince
Chairman 54 2022-04-09
Director/Board Member 45 2023-09-12
Director/Board Member 45 2022-04-09
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-3.12%-13.68% - 580M
-0.49%-2.71%+39.30%+114.07% 1,025B
-0.37%-4.44%+39.03%+66.07% 623B
+0.10%-1.96%+6.36%+74.38% 459B
-0.03%-2.82%+59.56%+39.69% 355B
-0.43%-3.69%+22.05%+39.89% 336B
-0.99%-2.15%+12.69%+25.54% 270B
-0.88%-4.40%-3.65%+9.59% 247B
-0.42%+0.30%+36.44%+51.54% 220B
-0.53%-1.46%+32.70%+96.82% 183B
Average -0.61%-2.02%+23.08%+57.51% 371.88B
Weighted average by Cap. -0.50%-2.11%+30.28%+69.41%

Financials

2024 2025
Net sales 394M 105M 93.21M 87.17M 79.43M 150M 10.1B 152M 1.05B 408M 5.15B 385M 16.53B 460M 123M 109M 102M 92.84M 175M 11.81B 177M 1.23B 477M 6.01B 451M 19.32B
Net income 79.85M 21.27M 18.89M 17.67M 16.1M 30.31M 2.05B 30.72M 214M 82.73M 1.04B 78.12M 3.35B 97.01M 25.84M 22.95M 21.46M 19.56M 36.82M 2.49B 37.33M 260M 101M 1.27B 94.91M 4.07B
Net Debt 42.83M 11.41M 10.13M 9.48M 8.63M 16.26M 1.1B 16.48M 115M 44.38M 559M 41.9M 1.8B 29.47M 7.85M 6.97M 6.52M 5.94M 11.19M 756M 11.34M 78.88M 30.54M 385M 28.83M 1.24B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
26-10-01 SAR 62.20 -1.50% 41,141
26-09-30 SAR 63.15 -0.08% 56,709
26-09-29 SAR 63.20 -0.78% 84,153
26-09-28 SAR 63.70 -0.31% 64,728
26-09-27 SAR 63.90 -0.47% 17,094
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
62.20SAR
Average target price
146.40SAR
Spread / Average Target
+135.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock